Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
Metabolic Effects of Antihypertensive Drugs
Status: Enrolling
Updated:  6/12/2014
mi
from
Gainesville, FL
Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
Metabolic Effects of Antihypertensive Drugs
Status: Enrolling
Updated: 6/12/2014
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A 6-Week Proof-of-Concept Study Evaluating the Safety and IOP-Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  6/24/2014
mi
from
Fort Worth, TX
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A 6-Week Proof-of-Concept Study Evaluating the Safety and IOP-Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 6/24/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluation of a Decision Support Tool
Primary Medication Adherence Phase 2 Evaluation of a Decision Support Tool
Status: Enrolling
Updated:  7/17/2014
mi
from
Boston, MA
Evaluation of a Decision Support Tool
Primary Medication Adherence Phase 2 Evaluation of a Decision Support Tool
Status: Enrolling
Updated: 7/17/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Hydroxyurea in Pulmonary Arterial Hypertension
Hydroxyurea in Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  7/29/2014
mi
from
Bethesda, MD
Hydroxyurea in Pulmonary Arterial Hypertension
Hydroxyurea in Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 7/29/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Implementing Evidence Based Treatment of Hypertension
Implementing Evidence-based Treatment of Hypertension
Status: Enrolling
Updated:  8/6/2014
mi
from
Iowa City, IA
Implementing Evidence Based Treatment of Hypertension
Implementing Evidence-based Treatment of Hypertension
Status: Enrolling
Updated: 8/6/2014
VA Medical Center, Iowa City
mi
from
Iowa City, IA
Click here to add this to my saved trials
Implementing Evidence Based Treatment of Hypertension
Implementing Evidence-based Treatment of Hypertension
Status: Enrolling
Updated:  8/6/2014
mi
from
Minneapolis, MN
Implementing Evidence Based Treatment of Hypertension
Implementing Evidence-based Treatment of Hypertension
Status: Enrolling
Updated: 8/6/2014
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function
The Effect of Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function in Hypertensive Patients: A Pilot Study
Status: Enrolling
Updated:  8/11/2014
mi
from
Omaha, NE
Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function
The Effect of Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function in Hypertensive Patients: A Pilot Study
Status: Enrolling
Updated: 8/11/2014
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health
Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health and Reduce the Risks of Preterm Delivery
Status: Enrolling
Updated:  8/26/2014
mi
from
Cincinnati, OH
Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health
Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health and Reduce the Risks of Preterm Delivery
Status: Enrolling
Updated: 8/26/2014
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS)
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS), an Assessment for Use in Clinical Settings Among English and Spanish-speaking Patients With Hypertension and Diabetes.
Status: Enrolling
Updated:  9/12/2014
mi
from
Chapel Hill, NC
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS)
A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS), an Assessment for Use in Clinical Settings Among English and Spanish-speaking Patients With Hypertension and Diabetes.
Status: Enrolling
Updated: 9/12/2014
Ambulatory Care Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Northwestern University and Access Community Health Network Medication Education Study
EHR-based Health Literacy Strategy to Promote Medication Therapy Management
Status: Enrolling
Updated:  9/26/2014
mi
from
Chicago, IL
Northwestern University and Access Community Health Network Medication Education Study
EHR-based Health Literacy Strategy to Promote Medication Therapy Management
Status: Enrolling
Updated: 9/26/2014
Access Community Health Network
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Las Vegas, NV
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
AB Clinical Trials
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Fort Lauderdale, FL
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Alan Graff, MD, PA
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
DeLand, FL
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Sarasota, FL
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Cardiovascular Center of Sarasota
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Chicago, IL
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Cedar-Crosse Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Glendale, AZ
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Clinical Research Advantage, Inc.
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Columbus, OH
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Columbus Clinical Research
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Muncie, IN
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Community Clinical Research Center
mi
from
Muncie, IN
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Oklahoma City, OK
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
COR Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Dayton, OH
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Dayton Clinical Research
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Honolulu, HI
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
East West Medical Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Encinitas, CA
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Encompass Clinical Research
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Bossier, LA
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Grace Research
mi
from
Bossier, LA
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Wichita, KA
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Jacksonville, FL
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Concord, CA
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
John Muir Health Network - The Osteoporosis Center
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Fargo, ND
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Lillestol Research LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Auburn, ME
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Maine Research Associates
mi
from
Auburn, ME
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Charlotte, NC
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Metrolina Internal Medicine
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Indianapolis, IN
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Greer, SC
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Mountain View Clinical Research
mi
from
Greer, SC
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Bellevue, WA
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Arlington Heights, IL
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Northwest Heart Clinical Research
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Oklahoma City, OK
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Greensboro, NC
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Pharmquest
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated:  10/10/2014
mi
from
Cleveland, OH
A Study of LY2623091 in Participants With High Blood Pressure
A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension
Status: Enrolling
Updated: 10/10/2014
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials